With growing demand for GLP-1s, their supply chain integrity is vital. This article shows how EU Good Distribution Practice (GDP) and data operations (DataOps) help people manage these temperature-sensitive medicines in Europe. GLP-1s: Temperature Control GLP-1 drugs, for diabetes and obesity, are showing promise for other conditions, increasing demand. Global sales hit $53.6B (approximately £42.34B […]
I was recently asked to travel to a country that was adjacent to a newly erupted war zone – missiles were raining down relatively nearby. The country I was visiting also has some stringent restrictions on travelling with medication (I’m a diabetic) so I was already somewhat apprehensive (even having been before!). The company sending
As the Maly IT team, we understand the benefits of adopting good practices in the pharmaceutical industry. Ever mindful that the health and well-being of individuals depends on the quality, safety, and efficacy of medicinal products. Therefore, we agree that helping our customers to assure adherence to stringent guidelines and regulations is paramount. What are
As demand for Glucagon-like peptide-1 (GLP-1) therapies grows, maintaining their integrity across the international supply chain is a complex logistical challenge. It requires meticulous cold chain management to prevent spoilage and to safeguard patient outcomes. This article aims to focus on managing temperature excursions for a specific category of products. It expands on a previous
Escalating demand for temperature-sensitive biologics, vaccines, and advanced therapies intensifies the challenge of maintaining stringent temperature control throughout the entire distribution network, argues Richard Maly. The Imperative of Temperature Control Temperature excursions are defined as any deviation from a pharmaceutical product’s specified temperature range during its storage, transport, or handling, as determined by the manufacturer’s
Our regular readers will know Maly is a company which specialises in helping innovators simplify, digitise, automate and control complex industrial and compliance processes. The Okuda no-code tool allows users to model and capture any process as a series of simple digital steps, ensuring each individual and team plays their part at the right time
Norfolk Hospital Joins Groundbreaking Generation Study Here at Maly IT, we’re really pleased to hear that our local Norfolk and Norwich University Hospital (NNUH) is taking part in the pioneering Generation Study. This national research project aims to transform how over 200 rare genetic conditions are diagnosed in newborns. The study will offer whole genome
Previously in Part 1, we identified examples from the bewildering array of different types of business process management tools. Let’s now explore some of the main challenges companies raise with these tools and how to overcome them. We’ll start with challenges directly related to the nature, adoption and use of these tools: 1. Complexity and
As businesses grow and mature they develop ever more processes that increase in length (number of steps), complexity (number of decision points & branches), actors (people required to interact with the process) and touchpoints (interactions with other data sets, applications or systems). Keeping track of and monitoring all of these processes as they grow and
The biopharmaceutical landscape is undergoing a significant transformation, driven by the increasing reliance on in silico simulations in drug discovery and therapeutics development. This computational approach offers a powerful tool for researchers. It allows for the prediction of drug-target interactions. Lead compounds can be optimised. The behaviour of molecules within biological systems can be simulated.
